CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Adjusts Price Target Gilead Sciences to $166 From $168, Maintains Overweight Rating

Neutral
AI Analysis

Summary

Morgan Stanley adjusted its price target for Gilead Sciences down slightly to $166 from $168 while maintaining an Overweight rating.

Importance:2/10
Sentiment:
0.00
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 8, 2026 9:26 AM

Read Original